ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)
NCT: NCT01534819 · COMPLETED
Brief Summary
The ANCHOR registry is a multi-center, post-market, non-interventional, non-randomized, prospective study. Subjects must sign an ICF prior to obtaining any study specific information. Subjects are eligible to be consented up to 30 days post-procedure. Enrolled subjects will be followed as per local 'standard of care' for up to 5 years post procedure. Study recommended follow-up is per SVS and ESVS guidance.
Frequently Asked Questions
What is ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)?
ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) is a clinical trial registered under NCT01534819. Current status: COMPLETED.
What is the status of NCT01534819?
The current status of NCT01534819 (ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)) is: COMPLETED.
When did ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) start?
ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) started on 2012-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.